Evidence map›Paper›PMID 36948850›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2023

[Diagnostic value of novel hepatic fibrosis markers in assessing cirrhosis in patients with chronic hepatitis C].

Q Kang, J X Liu, N Tan, H Y Chen, J L Pan, Y F Han, X Y Xu

Open access · greenAbstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Q KangDepartment of Infectious Diseases, Peking University First Hospital, Beijing 100034, China.
J X LiuDepartment of Gastroenterology, Peking University First Hospital, Beijing 100034, China.
N TanDepartment of Infectious Diseases, Peking University First Hospital, Beijing 100034, China.
H Y ChenDepartment of Infectious Diseases, Peking University First Hospital, Beijing 100034, China.
J L PanDepartment of Infectious Diseases, Peking University First Hospital, Beijing 100034, China.
Y F HanDepartment of Infectious Diseases, Peking University First Hospital, Beijing 100034, China.
X Y XuDepartment of Gastroenterology, Peking University First Hospital, Beijing 100034, China.
Peking University · CN

Funding

Beijing Municipal Science and Technology Commission of Major Projects D161100002716003National Science and Technology Major for Infectious Diseases 2017ZX10203202-003
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hepatitis C, ChronicAntiviral AgentsBiomarkersFibrosisHumansLiver CirrhosisMembrane ProteinsAntiviral AgentsBiomarkersMembrane ProteinsChitinase-3-like protein 1Chronic hepatitis CDirect antiviral agentsFibrosisGolgi protein 73

Identifiers

PMID36948850
PMCPMC12854836
OpenAlexW4360600551

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.